Akèy › Dyabèt Tip 2 › Texas
Etid klinik pou Dyabèt Tip 2 nan Texas
58 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Texas.
Vil nan Texas
- San Antonio37 etid
- Houston31 etid
- Dallas19 etid
- Austin12 etid
- Mesquite8 etid
- Pharr8 etid
- The Woodlands7 etid
- McKinney6 etid
- Lewisville5 etid
- Sugar Land5 etid
- Brownsville4 etid
- Killeen4 etid
- Round Rock4 etid
- Cypress4 etid
- Corpus Christi4 etid
- Fort Worth4 etid
- El Paso3 etid
- Grand Prairie3 etid
Tèks ofisyèl etid la (Anglè)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- Baylor Scott & White, Temple
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- Houston Methodist, Houston
- Baylor Scott & White, Temple
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06906640A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Texas Diabetes and Endocrinology - Central Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Privia Medical Group Gulf Coast, PLLC, Conroe
- ak 10 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Clinical Research - Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Headlands Research - Brownsville, Brownsville
- ak 25 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Amarillo Med Spec LLP, Amarillo
- Texas Diabetes & Endocrinology, Austin
- North Texas Endocrine Center, Dallas
- ak 6 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
Ap rekrite
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT06593327A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Hendrick Health, Abilene
- Gadolin Research, Beaumont
- CardioVoyage, LLC, Greenville
- ak 10 plis
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Endeavor Clinical Trials, San Antonio
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Houston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07776509Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- The University of Texas Health Science Center at San Antonio, San Antonio
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT02969798A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
- Velocity Clinical Research, Dallas, Dallas
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, DeSoto
- Research Site, El Paso
- Research Site, Houston
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Austin
- AURORA-2 Clinical Site, Brownsville
- AURORA-2 Clinical Site, DeSoto
- ak 10 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- M3 Wake Research - Dallas, Dallas
- University of Texas Southwestern Medical Center, Dallas
- SMS Clinical Research, LLC - 400 W. Kearney St, Mesquite
- ak 3 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Headlands Research Brownsville, Brownsville
- Velocity Clinical Research, Dallas
- South Texas Research Institute - Edinburg, Edinburg
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Juno Research, Houston
- Southern Endocrinology Associates, Mesquite
- Texas Diabetes & Endocrinology, P.A., Round Rock
- ak 2 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- IMA Clinical Research, Austin
- Private Practice - Dr. Laila A. Hassan, Houston
- Radiance Clinical Research, Lampasas
- ak 3 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07668388A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- University of Texas Southwestern Medical Center, Dallas
- JCCT- Juno NW Houston, Houston
- Consano Clinical Research, LLC, Shavano Park
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07415954Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Arlington Nephrology, PLLC., Arlington
- M3 Wake Research Dallas - Internal Medicine, Dallas
- Revival Research Institute, LLC, Dallas
- ak 10 plis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Dallas
- Research Site, Houston
- Research Site, Houston
- ak 6 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Amir Ali Hassan, MD, PA, Houston
- Consano Clinical Research, LLC, Shavano Park
Ap rekriteFaz 3
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Austin, Austin
- Velocity Clinical Research - Dallas, Dallas
- Juno Research, LLC, Houston
- ak 8 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Mercy Family Clinic, Dallas
- Velocity Clinical Research, Dallas, Dallas
- Biopharma Informatic, LLC, Houston
- ak 5 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Elligo Clinical Research Center, Austin
- Johnson County Clinical Trials Juno Bellaire, Bellaire
- Osvaldo A Brusco MD PA, Corpus Christi
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, San Antonio
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- PharmaTex Research, Amarillo
- Pinnacle Clinical Research, Austin
- Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe
- ak 20 plis
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Irving
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662044A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Dallas
- Research Site, McKinney
- Research Site, Paris
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Texas Diabetes & Endocrinology, Austin
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599982Quantifying Hepatic Mitochondrial Fluxes in Humans
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Aug 17, 2026 · NCT05305287A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
- Research Site, San Antonio
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Aug 12, 2026 · NCT07024823A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Research Institute of Dallas, Dallas
- Texas Childrens Hospital, Houston
- UT Health Houston, Houston
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122Polypill for Prevention of Cardiomyopathy
- UT Southwestern Medical Center, Dallas
Ap rekriteFaz 1/2
Laj 18 a 100 · Tout sèks · Mizajou Aug 4, 2026 · NCT06143566A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Houston
- Research Site, Round Rock
- Research Site, San Antonio
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07664553Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Texas Diabetes and Endocrinology, Austin
- Tekton Research, McKinney
- Tekton Research, San Antonio
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07521475Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Baylor College of Medicine, Houston
Ap rekrite
Laj 14 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07579702SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes
- Brooke Army Medical Center, San Antonio
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Jul 28, 2026 · NCT07674628SGLTi, Hepatic Glucose Production and Ketogenesis
- Texas Diabetes Institute/UH, San Antonio
Ap rekriteFaz 1
Laj 30 a 75 · Tout sèks · Mizajou Jul 17, 2026 · NCT05960656Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.